157 related articles for article (PubMed ID: 21353876)
1. Intracrine signaling mechanisms of activin A and TGF-β.
Gressner OA
Vitam Horm; 2011; 85():59-77. PubMed ID: 21353876
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Hepatology; 2009 Jun; 49(6):2021-30. PubMed ID: 19309720
[TBL] [Abstract][Full Text] [Related]
3. BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway.
Stewart A; Guan H; Yang K
J Cell Physiol; 2010 Jun; 223(3):658-66. PubMed ID: 20143330
[TBL] [Abstract][Full Text] [Related]
4. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
5. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
DaCosta Byfield S; Major C; Laping NJ; Roberts AB
Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
[TBL] [Abstract][Full Text] [Related]
6. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
7. Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Weiskirchen R; Gressner AM
Liver Int; 2008 Nov; 28(9):1207-16. PubMed ID: 18397232
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors.
Funaba M; Ikeda T; Murakami M; Ogawa K; Abe M
Cell Signal; 2005 Jan; 17(1):121-8. PubMed ID: 15451032
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of activin signal transduction.
Choi SC; Han JK
Vitam Horm; 2011; 85():79-104. PubMed ID: 21353877
[TBL] [Abstract][Full Text] [Related]
10. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver.
Ichikawa T; Zhang YQ; Kogure K; Hasegawa Y; Takagi H; Mori M; Kojima I
Hepatology; 2001 Nov; 34(5):918-25. PubMed ID: 11679962
[TBL] [Abstract][Full Text] [Related]
12. Activation of TGF-beta within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor.
Gressner OA; Lahme B; Siluschek M; Rehbein K; Herrmann J; Weiskirchen R; Gressner AM
J Cell Mol Med; 2008 Dec; 12(6B):2717-30. PubMed ID: 18266973
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the role of activin A and transforming growth factor beta in the regulation of AML12 cell growth.
Zhang YQ; Mashima H; Kanzaki M; Shibata H; Kojima I
Hepatology; 1997 Jun; 25(6):1370-5. PubMed ID: 9185755
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
15. TMEPAI, a transmembrane TGF-beta-inducible protein, sequesters Smad proteins from active participation in TGF-beta signaling.
Watanabe Y; Itoh S; Goto T; Ohnishi E; Inamitsu M; Itoh F; Satoh K; Wiercinska E; Yang W; Shi L; Tanaka A; Nakano N; Mommaas AM; Shibuya H; Ten Dijke P; Kato M
Mol Cell; 2010 Jan; 37(1):123-34. PubMed ID: 20129061
[TBL] [Abstract][Full Text] [Related]
16. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
[TBL] [Abstract][Full Text] [Related]
17. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
18. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation.
Castañares C; Redondo-Horcajo M; Magán-Marchal N; ten Dijke P; Lamas S; Rodríguez-Pascual F
J Cell Sci; 2007 Apr; 120(Pt 7):1256-66. PubMed ID: 17376964
[TBL] [Abstract][Full Text] [Related]
19. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.
Santander C; Brandan E
Cell Signal; 2006 Sep; 18(9):1482-91. PubMed ID: 16413747
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
